Advisor Group Holdings, Inc. Fibrogen Inc Transaction History

Advisor Group Holdings, Inc.

$42.2 Billion
Q3 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Fibrogen Inc stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 6,305 shares of FGEN stock, worth $2,206. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,305

Previous 6,605 4.54%

Holding current value

$2,206

Previous $5,000 60.0%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$0.33 - $1.26 $99 - $378	-300 Reduced 4.54%	6,305 $2,000
Q2 2024 Aug 13, 2024	BUY	$0.89 - $2.36 $1,339 - $3,551	1,505 Added 29.51%	6,605 $5,000
Q1 2024 May 10, 2024	BUY	$0.73 - $2.73 $2,627 - $9,825	3,599 Added 239.77%	5,100 $11,000
Q4 2023 Feb 12, 2024	SELL	$0.38 - $0.91 $43 - $104	-115 Reduced 7.12%	1,501 $1,000
Q3 2023 Nov 13, 2023	SELL	$0.79 - $2.83 $4,544 - $16,280	-5,753 Reduced 78.07%	1,616 $1,000
Q2 2023 Aug 10, 2023	BUY	$2.49 - $20.59 $1,354 - $11,200	544 Added 7.97%	7,369 $19,000
Q1 2023 May 12, 2023	SELL	$15.95 - $25.18 $29,619 - $46,759	-1,857 Reduced 21.39%	6,825 $127,000
Q4 2022 Feb 10, 2023	BUY	$13.27 - $17.73 $1,897 - $2,535	143 Added 1.67%	8,682 $139,000
Q3 2022 Nov 14, 2022	SELL	$11.4 - $14.6 $1,140 - $1,460	-100 Reduced 1.16%	8,539 $111,000
Q2 2022 Aug 10, 2022	BUY	$7.94 - $12.96 $404 - $660	51 Added 0.59%	8,639 $96,000
Q1 2022 May 04, 2022	BUY	$12.02 - $16.79 $47,058 - $65,732	3,915 Added 83.78%	8,588 $42,000
Q3 2021 Nov 05, 2021	SELL	$10.18 - $26.64 $36,230 - $94,811	-3,559 Reduced 43.23%	4,673 $47,000
Q2 2021 Aug 02, 2021	SELL	$18.57 - $35.68 $21,318 - $40,960	-1,148 Reduced 12.24%	8,232 $219,000
Q1 2021 May 13, 2021	BUY	$31.0 - $55.72 $8,897 - $15,991	287 Added 3.16%	9,380 $331,000
Q4 2020 Feb 10, 2021	BUY	$37.09 - $48.97 $125,809 - $166,106	3,392 Added 59.5%	9,093 $337,000
Q3 2020 Nov 12, 2020	BUY	$40.47 - $45.5 $33,590 - $37,765	830 Added 17.04%	5,701 $233,000
Q2 2020 Aug 14, 2020	BUY	$32.57 - $42.83 $6,188 - $8,137	190 Added 4.06%	4,871 $198,000
Q1 2020 May 18, 2020	BUY	$23.3 - $45.96 $109,067 - $215,138	4,681 New	4,681 $163,000

Others Institutions Holding FGEN

# of Institutions

Shares Held

47.1M

Call Options Held

387K

Put Options Held

672K

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Fibrogen Inc Transaction History